Do More, Plan Less: Data Quality Deconstructed at Global Clinical Trials

Data Quality Deconstructed:
Do more, plan less
Global Clinical Trials
14-Sep-2012 Boston

Eileen M. Daniel
Director, Clinical & Data Operations

©2012 Endo Pharmaceuticals, Inc. All rights reserved.

1

15+ years ago
New York City
Spring 1997

©2012 Endo Pharmaceuticals Inc. All rights reserved.

2

Today there is nothing new under the sun
… except maybe some clouds


3

During this talk, I will

–
–
–
–
–

remind us of fundamentals
provide facts about a global study
tell you where & why we liberally apply brakes
flashback to a deconstruction methodology
close with thoughts on site and study initiation


4

stating the obvious


5

We all know this
The clinical trials we sponsor are research studies.
– A study is conducted according to a well-defined study plan
– That well-defined study plan is the protocol

Clinical investigators are responsible for conducting studies in
accordance with the protocol.
We are obliged to oversee and keep sharp focus on:
– Protection of human subjects
– Integrity of study data
– Compliance with applicable regulations

To meet our oversight obligations we conspire to plan.


6

the plans (sigh)

© 2012 Endo Pharmaceuticals Inc. All rights reserved.

7

The plans for a global phase 3 study
– 3.5 FTEs with global responsibility
study leader | data manager | study specialist | clinical information mgr

– 450 subjects recruited from 120 sites
North America, Europe, India

– 10 service partners including 4 CROs

– All study data flows in electronically from three sources
eCRF, central laboratory, IVRS

– 1 protocol, 1 playbook and 7 global plans

Bladder cancer is challenging enough. Starting up was hard to do.


8

Starting up – forming our global study community

study
community

study community >600
+clinical investigators & team

study team >30
study team

clinical sub
team

clinical trial
manager

+partner project managers

clinical sub-team >10
trial manager
research scientist
statistician
data manager
project management
regulatory affairs
health economics
pharmacovigilance …

Alignment is possible so long as you manage the plans variables.


9

Oh boy … the plans! I didn’t want to read any of them
– Loads of variables
– $75,000* total cost for one
– Had to tease out
–
–
–
–

the redundant
the confounding
the conflicting
the work-inducing

– 90%** is NOT REGULATED
*I did not make this up
**I made this up

We needed a timeout!


10

forcing a slowdown at startup


11


12

Kick off meeting Study team preparation


13

Attention here please


14

pre-prep preparation… JDI

© 2012 Endo Pharmaceuticals Inc. All rights reserved.

15

The CI is not the only one waiting for a final protocol

Sometimes it is a game to see who can hold out the longest.


16

And They’re Off!

Final protocol to FPI: 12 weeks
ICF
CRF
DMP
DRP
SAP
Safety Plan
IDMC Charter
Monitoring Plan
Escalation Plan
Communication Plan
Clinical Supplies Plan
File Management Plan
Medical Monitoring Plan
Sponsor Oversight Plan
Project Management Plan


17


18

Hold up – deconstruct the protocol before inking any plans
–
–
–
–
–
–
–
–

Dissect for data
Make an inventory
Tie-back to protocol objectives
Take out the WANTs, leave the NEEDs
Dispense with the notion of a CRF page
Identify a single point of origin for every item
Draw a map to illustrate how it flows end to end
Know how and where it will be presented in the study report

– Accept this is an iterative process and it will be revisited. This is okay.

Ask the questions no one else wants to, confront the risks early and often.


19

Plans we find useful in a global, multi-regional study

protocol

–

the

–

a 2-page
tells us at a glance where we have transferred
obligations, the names of the people working our study and which organization’s SOPs are being followed

–

a PPT document with lots of white space called the
completed by our service partners

–

the
tasks based on study risk analyses

–

an
what, when, how and who without replication of content that should be sourced elsewhere

Sponsor Oversight Plan

playbook that documents the plays for the tasks

global monitoring plan that describes expectations for on-site and centralized monitoring

integrated data management & review plan that describes the

+ The most overlooked: the plan to share it all with our sites.


20

site & study initiation


21

New (?) approach to training
– Study Initiation Meeting
– No longer PI centric, no silo presentations
– Advance enlistment of trusted sites
– tell them they are coming along the way
– start them up early & invest too much time
– engage them in planning

– Integrated delivery of study information
– simulate screening a subject & processing through study

– Service & technology providers are team members
– Study team intends to learn as much as they teach

First be armed with real-world qualitative experience, then go large.


22

Build a sense of community & keep it online


23

Do More, Plan Less: Data Quality Deconstructed at Global Clinical Trials

Do More, Plan Less: Data Quality Deconstructed at Global Clinical Trials

Recommended

Recommended

More Related Content

Similar to Do More, Plan Less: Data Quality Deconstructed at Global Clinical Trials

Similar to Do More, Plan Less: Data Quality Deconstructed at Global Clinical Trials (20)

More from ConferenceForum

More from ConferenceForum (20)

Recently uploaded

Recently uploaded (20)

Do More, Plan Less: Data Quality Deconstructed at Global Clinical Trials